Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 12/6/2024Recent Executive Moves
  • 12/6/2024CDE Seeks Comments on Draft ICH Guidelines M15
  • 12/6/2024Medical Costs in Mainland China and Hong Kong to Grow More Slowly Than...
  • 12/6/2024China's Expanding Proton Therapy Market: Key Drivers
  • 12/6/2024Implications of China's Growing Influence in Global Pharma / API Suppl...
  • 12/5/2024GSK and Zhifei Deepen Collaboration to Target RSV Vaccine Development
  • 12/5/2024SK Biopharm Advances Epilepsy Treatment in China with NDA Submission ...
  • 12/5/2024Cinclus Wins Marketing Approval in China for GERD Drug Linaprazan Glur...
  • 12/5/2024Abbisko’s PRMT5*MTA Inhibitor ABSK131 Granted IND Clearance from the ...
  • 12/4/2024GSK Secures $1B Option Deal for DualityBio's Preclinical ADC
  • 12/4/2024Everest Medicines Announces Positive Results in Preliminary Analysis o...
  • 12/4/2024CDE Issues the List of Reference Formulations for GQCE Studies (85th B...
  • 12/3/2024HUTCHMED and Innovent's ELUNATE and TYVYT Combo Win Chinese Condi...
  • 12/3/2024NH DB6: Global and Chinese Consumer Healthcare Market: MAT Q2/2024 Tr...
  • 12/3/2024Signet Thera Secures Over CNY 70M to Advance Targeted Cancer Drug Deve...
  • 12/3/2024PharmaMar/Luye's Lurbinectedin Gains Approval in China for Treating Me...
  • 12/3/2024NHC Minister Meets with Sanofi and BioMérieux Bosses to Strengthen Si...
  • 12/3/2024Sanofi Allocates €1 Billion for New Insulin Manufacturing Facility in...
  • 12/3/2024CMS Gains Licenses Class 1 New Drug Targeting Gout and Hyperuricemia f...
  • 12/2/2024UCB Closes Divestment from Neurology and Allergy Portfolio in China, ...
  • 12/2/2024Allink Biotherapeutics Secures $42M Series A to Advance Oncology and I...
  • 12/2/2024Hangzhou Jiuyuan Gene Engineering Debuts on Hong Kong Stock Exchange
  • 12/2/2024Merck's Recarbrio Approved in China for Severe Bacterial Pneumonia
  • 12/2/2024Minghui Pharma Reports Positive Phase III Results for MH004 in Atopic ...
  • 12/2/2024Shanghai Cell Therapy Group Submits Application Proof for Hong Kong Li...
  • 12/2/2024Affinity Biopharma Raises Over CNY 400M in Series B2 to Advance Tumor-...
  • 12/2/2024Zambon's Xadago (Safinamide) Gains Chinese Approval for Parkinson's Di...
  • 12/2/2024Nanjing Leads Biolabs Files for Hong Kong IPO
  • 12/2/2024Miracogen to Present Phase II Data on MRG003 at ESMO Asia 2024  
  • 12/2/2024Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the ...
  • Page:20/47 Total number of articles:1389: [First][<<] [18] [19] [20] [21] [22] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group